Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL.

Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...

The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

President Donald Trump on Wednesday moved to dislodge a cornerstone of modern civil rights law through a sweeping executive order that strips the federal government of the key tool it used to ...

Current evidence overstates the impact of eco-labels on food products and menus. But it doesn’t mean we should stop using ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

Individual and Public Implications of the Myocardial Infarction Definition e643 40. Global Perspectives of the Definition of Myocardial Infarction e644 41. Using the Universal Definition of Myocardial ...

The dosing interval for ixekizumab may be extended in some patients with plaque psoriasis, and switching between biologics ...

Abstract: The evaluation of the effectiveness of global navigation satellite system (GNSS) spoofing and jamming equipment is not only an important means of enhancing the power of modern satellite ...

The aim of this study was to determine the efficacy of a speech pathology intervention programme ... Thus, 43 participants were included in the treatment group and 44 in the placebo group. The mean ...